Nalaganje...
Formulary Selection Criteria for Biosimilars: Considerations for US Health-System Pharmacists
Pharmacists will play a key role in evaluating biosimilars for formulary inclusion in the United States. As defined by US law, a biosimilar is a biologic that is highly similar to its reference product, notwithstanding minor differences in clinically inactive components, and should not have clinical...
Shranjeno v:
| izdano v: | Hosp Pharm |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Thomas Land Publishers, Inc.
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4252185/ https://ncbi.nlm.nih.gov/pubmed/25477613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hpj4909-813 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|